LAWRENCE, Mass., June 12, 2014 /PRNewswire/ -- NxStage
Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative
dialysis products, is excited to share a current NxStage® System
One™ user's story of freedom and discovery. When Don was diagnosed
with kidney failure in 2012, it quickly became apparent that
three-times-weekly in-center dialysis treatment would limit his
time with his two passions – spending time with his young
grandchildren and riding his motorcycle. Determined to reclaim the
life he loved pre-dialysis, Don began more frequent home
hemodialysis (HHD) treatment with the NxStage® System One™. More
frequent HHD has helped Don reclaim his family life and get back to
riding his motorcycle.
"Once I discovered NxStage and started more frequent at-home
therapy with the System One, I felt myself come back from a really
dark place," said Don. "One of my greatest joys is spending time
with my grandchildren again, and all my goals are attainable now.
It's a wonderful and life-changing feeling."
While on three-times-weekly in-center dialysis, Don's free time
was spent recovering from treatment, limiting his time playing with
his grandchildren and riding his motorcycle. After one year of
travelling to and from the dialysis center, and a rigid treatment
schedule that triggered feelings of depression and solitude, Don
took matters into his own hands. He searched for an alternative and
discovered NxStage's portable home hemodialysis machine. With help
from his mother and trained care partner, Don now performs more
frequent home hemodialysis and has experienced a positive change in
his physical and mental health, as well as shorter recovery time
after each treatment. These benefits have allowed Don to reclaim
time with his family and his personal hobbies.
"Every day we strive to provide patients with the life changing
benefits of our therapy. We are both humbled and inspired by what
our patients tell us they are able to achieve and regain while on
our therapy," stated Joe Turk,
President of NxStage. "Their stories drive our continued
innovation."
Hear Don share his journey with kidney failure in his video,
http://ww2.nxstage.com/Don.html. To learn more about NxStage
and the System One, visit www.nxstage.com or join the conversation
on Facebook at facebook.com/NxStage, Twitter at @NxStage and
YouTube at youtube.com/user/NxStage.
Despite the health benefits that more frequent home
hemodialysis may provide to those with chronic kidney disease, this
form of therapy is not for everyone. The reported benefits of home
hemodialysis may not be experienced by all patients. The risks
associated with hemodialysis treatments in any environment include,
but are not limited to, high blood pressure, fluid overload, low
blood pressure, heart-related issues, and vascular access
complications. The medical devices used in hemodialysis therapies
may add additional risks including air entering the bloodstream and
blood loss due to clotting or accidental disconnection of the blood
tubing set. Certain risks are unique to the home. Treatments at
home are done without the presence of medical personnel and on-site
technical support. Patients and their partners must be trained on
what to do and how to get medical or technical help if
needed.
About the NxStage System One
The NxStage System One is
the first and only truly portable hemodialysis system cleared for
home use by the U.S. Food & Drug Administration (FDA). Its
simplicity and revolutionary size (just over a foot tall) are
intended to allow convenient use in patients' homes and give
patients the freedom to travel with their therapy. When combined
with the NxStage PureFlow SL Dialysis Preparation System, patients
are able to further simplify, using ordinary tap water to create
dialysis fluid. Unlike conventional hemodialysis systems, the
System One requires no special infrastructure to operate. Under the
guidance of their physician, patients can use the NxStage System
One, with their trained partners, where, how and when it best meets
their needs - at home or on vacation and at a medically appropriate
treatment frequency. http://www.nxstage.com/.
About NxStage Medical
NxStage Medical Inc. (Nasdaq:
NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops,
manufactures and markets innovative products for the treatment of
ESRD and acute kidney failure. For more information on NxStage and
its products, please visit the Company's website at
www.nxstage.com.
Forward-Looking Statements
This release contains
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements contained
in this release that are not clearly historical in nature are
forward-looking, and the words "anticipate," "believe," "expect,"
"estimate," "plan," and similar expressions are generally intended
to identify forward-looking statements. Actual results may differ
materially from those indicated by these forward-looking statements
as a result of various important factors including those that are
discussed in NxStage's filings with the Securities and Exchange
Commission, including its Quarterly Report on Form 10-Q for the
quarter ended March 31, 2014. NxStage
is under no obligation to (and expressly disclaims any such
obligation to) update or alter its forward-looking statements,
whether as a result of new information, future events or
otherwise.
Media Contact:
Meredith D'Agostino
451 Marketing, on behalf of NxStage Medical, Inc.
mdagostino@451marketing.com
(516) 884-7162
Video - http://youtu.be/9jnLI_ADXPM
Logo - http://photos.prnewswire.com/prnh/20110503/MM94799LOGO
SOURCE NxStage Medical Inc.